Human PD-L1 inhibitor V

Human PD-L1 inhibitor V

• CAS Number: 2815311-61-4
• UNSPSC Description: Human PD-L1 inhibitor V, a human PD-1 protein binding peptide with a Kd value of 3.32 μM. Human PD-L1 inhibitor V inhibit the interaction of hPD-1/hPD-L1[1].
• Target Antigen: PD-1/PD-L1
• Type: Peptides
• Related Pathways: Immunology/Inflammation
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/human-pd-l1-inhibitor-v.html
• Purity: 99.04
• Solubility: H2O
• Smiles: OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@H](C(N[C@H](C(O)=O)CCC(N)=O)=O)CC2=CC=C(C=C2)O)=O)=O)=O)=O)=O)=O)=O)NC([C@H](CC(O)=O)NC([C@@H](N)CC(C)C)=O)=O
• Molecular Weight: 1485.71
• References & Citations: [1]Qiao Li, et al. Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor. Oncotarget. 2016 Oct 4;7(40):64967-64976.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported